BANK OF AMERICA CORP /DE/ - HCW BIOLOGICS INC ownership

HCW BIOLOGICS INC's ticker is and the CUSIP is 40423R105. A total of 14 filers reported holding HCW BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of HCW BIOLOGICS INC
ValueSharesWeighting
Q4 2022$8042
+250.0%
0.00%
Q4 2021$0120.00%
Other shareholders
HCW BIOLOGICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 56,600$155,0000.00%
HighTower Advisors, LLC 215,598$588,0000.00%
Focused Wealth Management, Inc 1,000$3,0000.00%
UBS Group AG 1,705$5,0000.00%
TWO SIGMA INVESTMENTS, LP 51,200$140,0000.00%
WELLS FARGO & COMPANY/MN 44$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 53,169$145,0000.00%
STATE STREET CORP 20,546$56,0000.00%
MORGAN STANLEY 500$1,0000.00%
View complete list of HCW BIOLOGICS INC shareholders